Back to Awarded Treatment Trials


Awarded Trial: 12T-002

Grant ID

12T-002

Illness

schizophrenia

Primary Drug/Intervention

Cholecalciferol (vitamin D-3)

Primary Dosage

4000 IU/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Cancelled

Investigator

Clelland

Sample Size

80

Duration of Study Period for Each Subject

70 days

Outcome Measurements

N/A

Results

Study was cancelled because of lack of study sites with sufficient patient numbers

Publication

N/A

Link

N/A

PI Name

James Clelland

Degree

PhD

Center

Langone Medical Center

Institution

New York University

Address

550 1st Avenue

City or Town

New York

State or Province

NY

Zip or Postal Code

10016

Country

USA

Email Address

jc150@nyu.edu